Police Pilot Roadside Cannabis Test in Missouri

April 20, 2023 · Green Market Report

How police officers plan to use the device during simple traffic stops is unclear.

A neuro-diagnostic company, Oculogica, said it has launched a pilot program to trial a new roadside cannabis test that supposedly provides immediate results, with a wider release slated toward the end of the year.

The binocular-looking device, dubbed OcuPro, detects recent cannabis use and impairment within 60-90 minutes using eye-tracking-based algorithms, the company said, which would be an improvement over current tests that can only detect the general presence of tetrahydrocannabinol (THC) in the body.

The OcuPro device can be administered by police officers within 45 seconds, allowing them to determine if a driver is impaired due to recent cannabis use.

The technology is based on studies of several hundred cannabis users, and Oculogica’s data scientist, Darryl Mayeaux, emphasized in a statement the importance of establishing a definition of impairment that will not inappropriately define unimpaired people as impaired.

Companies and law enforcement syndicates have been searching for a reliable test for impairment due to recent consumption for a while now, as the presence of cannabis in the body does not necessarily mean visible intoxication.

“Cannabis presence in the body does not equal impairment,” said CEO Rosina Samadani. “Use is not illegal in many states.”

“Driving while impaired, however, is. OcuPro addresses a huge unmet need for a scientifically and clinically validated test for impairment due to recent cannabis use.”

In addition to law enforcement, OcuPro will also try to solicit its product to manufacturing facilities and workplaces.

For now, the company said law enforcement has the most immediate need, citing data that explored the effect cannabis has on impaired driving crashes in the year following legalization.

Pilot sites for OcuPro include police districts in Missouri, and discussions are underway with several other jurisdictions, such as Seattle, WA. The device will be available beyond the pilot sites in late 2023.

Oculogica said the breathalyzer builds on the technology used in the company’s first FDA-cleared concussion diagnostic that does not require a pre-injury baseline. The company was founded by a neurosurgeon and develops and manufactures products with eye-tracking-based algorithms. (Full Story)

In category:Legal
Tags:
Next Post

ACLU Defends Afroman In Lawsuit From Police Who Are Upset He Used Footage Of Their Marijuana Raid On His Home In Music Video

The American Civil Liberties Union (ACLU), along with the organization’s Ohio chapter, has filed a proposed amicus brief supporting Afroman in a civil lawsuit brought against him by seven police officers who are upset the hip hop artist used footage…
Read
Previous Post

GOP Congressman And AOC Refile Bill To Incentivize State-Level Marijuana Expungements

Reps. Dave Joyce (R-OH) and Alexandria Ocasio-Cortez (D-NY) have reintroduced a bipartisan bill to encourage state and local governments to expunge marijuana records in their jurisdictions. The lawmakers filed the Harnessing Opportunities by Pursuing Expungement (HOPE) Act on Tuesday, describing…
Read
Random Post

The Canadian Government Has Collected Over $1 Billion in Cannabis Taxes Since Legalization Began in 2018

Since recreational use of cannabis became legal in Canada in 2018, the federal government of that country has imposed a total duty on cannabis products of over 1 billion Canadian dollars ($740 million). Executives expect that the government would ease the…
Read
Random Post

STIIIZY Stands Out at Rolling Loud’s 10-Year Anniversary Event

“It’s like nothing I’ve ever seen before,” said an eager Rolling Loud attendee. “It’s cool to attend the show, listen to killer music and see what a mock cannabis grow might look like. You know I got my selfie in!”…
Read
Random Post

South Dakota Considers Increasing Possession Limits for Cannabis Patients

Proposed medical cannabis rule changes in South Dakota would allow for higher possession limits for edibles and would raise registration fees for medical cannabis companies from $5,000 to $5,310, KELO reports. Under the proposal, patients could possess up to 15 grams of edible oils…
Read
Random Post

New York regulators issue first cannabis product recall

New York issued what is believed to be its first cannabis product recall after the discovery that a single lot of gummies “did not undergo the required testing for consumer safety and product quality.” The product, “Jenny’s Zee Zee gummies, 2:1 THC/CBN,”…
Read